Iridex (IRIX) Capital Expenditures (2011 - 2026)
Iridex's (IRIX) quarterly Capital Expenditures came in at $101000.0 in Q2 2026, up 205.21% year-on-year from $33092.2 in Q2 2025, and up 132.9% quarter-over-quarter from -$307000.0 in Q1 2026.
Iridex (IRIX) Capital Expenditures (2011 - 2026) Analysis & Trends
Iridex's Capital Expenditures history runs 16 years deep, the most recent figure standing at $101000.0 for Q2 2026.
- On a quarterly basis, Capital Expenditures rose 205.21% year-over-year to $101000.0 in Q2 2026; TTM through Apr 2026 was -$73000.0, a 15.12% increase from a year earlier, with the FY2026 full-year figure at -$270000.0, down 2176.92% from the prior year.
- Capital Expenditures climbed to $101000.0 in Q2 2026 per IRIX's latest filing, from -$307000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $708000.0 in Q4 2022 and bottomed at -$307000.0 in Q1 2026.
- The 5-year median for Capital Expenditures is $72000.0 (2023), against an average of $89111.1.
- Across the five-year window, Capital Expenditures sank 3300.0% in 2025 and surged 205.21% in 2026, its largest moves.
- Year by year, Capital Expenditures stood at $107000.0 in 2022, then jumped by 86.92% to $200000.0 in 2023, then sank by 30.5% to $139000.0 in 2024, then advanced by 13.67% to $158000.0 in 2025, then plunged by 36.08% to $101000.0 in 2026.
- Per Business Quant, the three latest IRIX Capital Expenditures figures stand at $101000.0 (Q2 2026), -$307000.0 (Q1 2026), and $158000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 76.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -85.46 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 178.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Iridex | 15.93 Mn | 11.33 Mn | 4.74 Mn | 101,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 101,000.00 |
| Apr 4, 2026 | 101,000.00 |
| Jan 3, 2026 | -307,000.00 |
| Jan 3, 2026 | -307,000.00 |
| Sep 27, 2025 | 158,000.00 |
| Sep 27, 2025 | 158,000.00 |
| Jun 28, 2025 | -25,000.00 |
| Jun 28, 2025 | -25,000.00 |
| Mar 29, 2025 | -96,000.00 |
| Mar 29, 2025 | -96,000.00 |
| Dec 28, 2024 | 139,000.00 |
| Dec 28, 2024 | 139,000.00 |
| Sep 28, 2024 | -151,000.00 |
| Sep 28, 2024 | -151,000.00 |
| Jun 29, 2024 | 22,000.00 |
| Jun 29, 2024 | 22,000.00 |
| Mar 30, 2024 | 3,000.00 |
| Mar 30, 2024 | 3,000.00 |
| Dec 30, 2023 | 200,000.00 |
| Dec 30, 2023 | 200,000.00 |